FRA
Front Row Advisors’s GT Biopharma GTBP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4 | Hold |
1
| – | – | ﹤0.01% | 534 |
|
|
2025
Q1 | $2 | Buy |
+1
| New | +$2 | ﹤0.01% | 510 |
|
|
2024
Q3 | – | Sell |
-1
| Closed | -$3 | – | 647 |
|
|
2024
Q2 | $3 | Hold |
1
| – | – | ﹤0.01% | 941 |
|
|
2024
Q1 | $4 | Sell |
1
-1
| -50% | -$4 | ﹤0.01% | 927 |
|
|
2023
Q4 | $15 | Hold |
2
| – | – | ﹤0.01% | 470 |
|
|
2023
Q3 | $14 | Hold |
2
| – | – | ﹤0.01% | 917 |
|
|
2023
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 912 |
|
|
2023
Q1 | $0 | Buy |
+2
| New | – | ﹤0.01% | 924 |
|